Thu, Apr 07
|Online Event, Webinar via Zoom
HIV Masterclass - High viral load on a Dolutegravir based ART regimen
Learn Practical Approaches to HIV Care. Only active members are eligible for CPD accredited certificates.
Time & Location
Apr 07, 2022, 6:00 PM – 7:30 PM GMT+2
Online Event, Webinar via Zoom
About the event
HIV Masterclass - High viral load in a Dolutegravir based ART regimen
The Human Immunodeficiency Virus type 1 (HIV-1) integrase inhibitor Dolutegravir is recommended in treatment guidelines as first-line therapy for HIV-1 infection and is characterized by high antiviral potency and a high genetic barrier to the emergence of resistance. Few cases of virologic failure of Dolutegravir first-line therapy have been reported, but the relevance of resistance-associated mutations in these cases is unclear. This webinar will review a practical approach to the assessment and management of patients with a high VL on a Dolutegravir based ART regimen.
Date: 07 April 2022
Time: 18:00 - 19:30
Topic: High viral load in a Dolutegravir based ART regimen
Presenter: Dr Lesego Mawela, HIV Clinician
(N.B) After registering, you will receive a confirmation email containing information about joining the webinar.
For enquiries:
Email: info@clinicalcareplatform.com
Call/WhatsApp: 064 543 3928
Website: www.clinicalcareplatform.com